Kern David M, Sorum Ben, Mali Sonali S, Hoel Christopher M, Sridharan Savitha, Remis Jonathan P, Toso Daniel B, Kotecha Abhay, Bautista Diana M, Brohawn Stephen G
Department of Molecular & Cell Biology, University of California Berkeley, Berkeley, California 94720, USA.
Helen Wills Neuroscience Institute, University of California Berkeley, Berkeley, California 94720, USA.
bioRxiv. 2021 Jan 26:2020.06.17.156554. doi: 10.1101/2020.06.17.156554.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the coronavirus disease 2019 (COVID-19). SARS-CoV-2 encodes three putative ion channels: E, 8a, and 3a. 3a is expressed in SARS patient tissue and anti-3a antibodies are observed in patient plasma. 3a has been implicated in viral release, inhibition of autophagy, inflammasome activation, and cell death and its deletion reduces viral titer and morbidity in mice, raising the possibility that 3a could be an effective vaccine or therapeutic target. Here, we present the first cryo-EM structures of SARS-CoV-2 3a to 2.1 Å resolution and demonstrate 3a forms an ion channel in reconstituted liposomes. The structures in lipid nanodiscs reveal 3a dimers and tetramers adopt a novel fold with a large polar cavity that spans halfway across the membrane and is accessible to the cytosol and the surrounding bilayer through separate water- and lipid-filled openings. Electrophysiology and fluorescent ion imaging experiments show 3a forms Ca-permeable non-selective cation channels. We identify point mutations that alter ion permeability and discover polycationic inhibitors of 3a channel activity. We find 3a-like proteins in multiple and lineages that infect bats and humans. These data show 3a forms a functional ion channel that may promote COVID-19 pathogenesis and suggest targeting 3a could broadly treat coronavirus diseases.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是引发2019冠状病毒病(COVID-19)的病毒。SARS-CoV-2编码三种假定的离子通道:E、8a和3a。3a在SARS患者组织中表达,且在患者血浆中可检测到抗3a抗体。3a与病毒释放、自噬抑制、炎性小体激活及细胞死亡有关,其缺失可降低小鼠体内的病毒滴度和发病率,这增加了3a可能成为有效疫苗或治疗靶点的可能性。在此,我们展示了首个分辨率达2.1 Å的SARS-CoV-2 3a的冷冻电镜结构,并证明3a在重构脂质体中形成离子通道。脂质纳米盘内的结构显示,3a二聚体和四聚体呈现出一种新型折叠结构,具有一个大的极性腔,该腔横跨膜的一半,可通过单独的充满水和脂质的开口与细胞质和周围双层膜相通。电生理学和荧光离子成像实验表明,3a形成了钙离子可渗透的非选择性阳离子通道。我们鉴定出改变离子通透性的点突变,并发现了3a通道活性的聚阳离子抑制剂。我们在感染蝙蝠和人类的多种病毒株系中发现了类似3a的蛋白质。这些数据表明,3a形成了一个功能性离子通道,可能促进COVID-19的发病机制,并提示靶向3a可能广泛治疗冠状病毒疾病。